In today’s complex healthcare landscape, patient outcomes depend on a diverse network of stakeholders far beyond the prescribing physician. Join us as we explore why traditional Medical Affairs engagement models need to evolve and examine strategies for building meaningful relationships with nurses, pharmacists, patients, advocacy groups, and other influential voices in healthcare delivery.

Whether you’re considering broadening your current engagement strategy or looking to understand the evolving Medical Affairs landscape, this session will provide valuable insights and practical guidance for multi-stakeholder engagement.

Learning Objectives

  1. Recognize key non-prescribing stakeholder groups that influence patient outcomes in modern healthcare delivery.
  2. Gain insights on why traditional Medical Affairs engagement models need to evolve to address today’s complex healthcare landscape.
  3. Determine successful strategies and practical approaches for engaging diverse healthcare stakeholders based on real-world industry experiences.
Moderator: Helen Langan

Moderator: Helen Langan

EVP, Medical Affairs Strategy and Transformation, HCG
Speaker: Lucy Turner

Speaker: Lucy Turner

Medical Lead, GI Cancers and Emerging Portfolio, Europe and Canada, AstraZeneca
Speaker: Gurinder S. Sidhu

Speaker: Gurinder S. Sidhu

U.S. Antiviral Medical Lead, Senior Director, Pfizer

Speaker: Alex Schepart, PharmD, MBA

Speaker: Alex Schepart, PharmD, MBA

Senior Director, Medical Affairs, Shionogi Inc.